Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $180.96 | 6 | 60.5% |
| Education | $118.10 | 4 | 39.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $132.54 | 4 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $110.41 | 2 | $0 (2019) |
| Shire North American Group Inc | $34.61 | 3 | $0 (2017) |
| AbbVie Inc. | $21.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $21.50 | 1 | AbbVie Inc. ($21.50) |
| 2020 | $29.99 | 1 | Allergan, Inc. ($29.99) |
| 2019 | $154.84 | 3 | Otsuka America Pharmaceutical, Inc. ($92.29) |
| 2018 | $40.00 | 1 | Allergan Inc. ($40.00) |
| 2017 | $52.73 | 4 | Shire North American Group Inc ($34.61) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $92.29 | General |
| Category: PSYCHIATRY | ||||||
| 01/08/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2019 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2018 | Allergan Inc. | VIIBRYD (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Education | In-kind items and services | $18.12 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 207 | 366 | $73,213 | $26,674 |
| 2022 | 6 | 275 | 433 | $93,692 | $32,616 |
| 2021 | 7 | 412 | 734 | $170,387 | $60,734 |
| 2020 | 10 | 586 | 1,094 | $273,954 | $86,337 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 188 | $34,227 | $10,909 | 31.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 67 | $18,297 | $5,902 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 45 | $12,402 | $5,865 | 47.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 25 | 37 | $2,309 | $1,755 | 76.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $2,618 | $1,369 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 15 | $3,360 | $875.88 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 197 | $35,866 | $10,291 | 28.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 59 | $16,260 | $8,652 | 53.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 110 | $30,040 | $8,208 | 27.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 40 | $7,579 | $4,063 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 14 | $3,136 | $818.71 | 26.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 11 | 13 | $811.20 | $583.11 | 71.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 121 | 131 | $36,104 | $19,806 | 54.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 131 | 318 | $57,895 | $17,330 | 29.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 89 | 212 | $57,895 | $16,657 | 28.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 29 | $5,522 | $2,999 | 54.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 20 | 20 | $9,516 | $2,749 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,454 | $871.64 | 35.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 11 | $1,001 | $321.86 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 151 | 431 | $117,702 | $34,242 | 29.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 115 | 318 | $57,895 | $17,675 | 30.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 75 | 84 | $23,150 | $13,103 | 56.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 88 | 96 | $45,677 | $10,129 | 22.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 54 | 59 | $10,846 | $3,308 | 30.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 36 | 38 | $10,075 | $2,861 | 28.4% |
About Dr. Jeffrey Bradley, MD
Dr. Jeffrey Bradley, MD is a Psychiatry healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891807285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Bradley, MD has received a total of $299.06 in payments from pharmaceutical and medical device companies, with $21.50 received in 2021. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($180.96).
As a Medicare-enrolled provider, Bradley has provided services to 1,480 Medicare beneficiaries, totaling 2,627 services with total Medicare billing of $206,362. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Joplin, MO
- Active Since 08/31/2006
- Last Updated 08/13/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1891807285
Products in Payments
- VRAYLAR (Drug) $114.04
- ABILIFY MAINTENA (Drug) $92.29
- VIIBRYD (Drug) $40.00
- VYVANSE (Drug) $23.47
- REXULTI (Drug) $18.12
- MYDAYIS (Drug) $11.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Joplin
Dr. Modaser Shah, M.d, M.D
Psychiatry — Payments: $689.84
Lisset Diaz
Psychiatry — Payments: $611.77
Allison Smith, D.o, D.O
Psychiatry — Payments: $476.90
Nauman Ashraf, M.d, M.D
Psychiatry — Payments: $349.36
Matthew Krahl
Psychiatry — Payments: $336.36
Aneel Kumar, Md, MD
Psychiatry — Payments: $327.63